Zurück
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Pharm Control Ltd.: Pharm Control Ltd. Victim of Short Selling
Mar 22, 2007 (M2 PRESSWIRE via COMTEX) -- Pharm Control Ltd. (Other OTC: PMCL.PK) management is in the process of ordering a current Non Objecting Beneficial Owners list (NOBO list) from ADP Investor Communications. This is in response to the various emailssent and calls made to the Company's offices concerning possible short selling of the Company's stock.
The NOBO list shows a more complete and comprehensive shareholder profile than is typically available on a shareholder list provided by a transfer agent. In addition, management will order Depository Trust Corporation (DTC) reports for further examination. Both lists will be utilized to uncover possible short positions.
The NOBO list will be used to determine the naked short position in Pharm Control's common stock. The NOBO list will be compared to the reports from the DTC which contains data regarding all brokers and amounts of shares being held for investors. These lists will be used to get a total amount of shares owned by all shareholders and any naked short positions. The findings will then be reported to the NASD (National Association of Securities Dealers) to take action against the violators of the naked short regulations.
The company will take all necessary action to protect the value of shareholder investments and the steps now being taken exhibit the Company's response to the various emails send and calls made to our offices by investors.
About Pharm Control Ltd.
Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.
Safe Harbor Statement
The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.
CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. e-mail: pmclinfo@yahoo.com Tel: +1 212 252 4521
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
Bulletin Winning
